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Synopsis: 
The substitution of the HNMe2 in (HNMe2)B(Azolyl)3 (Azolyl = pyrazolyl, methimazolyl) by a range of N-
donors provides a high yielding route to neutral tripodal ligands. The IR spectra of Mn(I) tricarbonyl 
complexes of the ligands allows comparison of their donor properties with the anionic parent Tp and Tm 
ligands and shows them to be only marginally weaker donors. 
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Abstract 
The dimethylamine in the adducts [(HNMe2)B(azolyl)3] (azolyl = methimazolyl, pyrazolyl), obtained by 
reaction of the azole with B(NMe2)3, can readily be substituted with a range of nitrogen donors to provide new 
charge-neutral, tripodal ligands in high yield. This observation has lead to a revision of an earlier 
interpretation of the mechanism of the formation of these species. The donor properties of the ligands 
[(NMI)B(azolyl)3] (NMI = N-methylimidazole) have been compared with their anionic analogues 
[HB(azolyl)3]
-
 by synthesis of their manganese(I)tricarbonyl complexes and comparison of their infra red co 
energies. This comparison indicates that the new neutral ligands are only marginally weaker donors than the 
corresponding anionic hydrotris(azolyl)borate ligands. This may be explained by the ability of the attached 
NMI ring to stabilize a positive charge remote from the coordinated metal, which may also account for the 
fact that the [(NMI)B(pyrazolyl)3] ligand is a substantially stronger donor than the similarly neutral 
tris(pyrazolyl)methane ligand. 
 
Introduction 
The synthesis of tripodal borate-centered ligands through reaction of a tetrahydroborate salt with an azole 
heterocycle is well established and follows Trofimenko’s original methodology for the preparation of the 
hydrotris(pyrazolyl)borate (Tp) ligand (Scheme 1).
[1]
 The reaction is conventionally conducted in the absence 
of a solvent in a so called melt reaction, but high boiling hydrocarbon or ether solvents have also been used.
 
Ligands synthesized from a wide range of substituted pyrazoles are accessible via this route.
[2]
 Analogous 
neutral tripods such as the tris(pyrazolyl)methanes [RC(pz)3]
[3]
 and phosporyl centered ligands [O=P(pz)3]
[4]
 
have also been developed. More recently a new family of sulfur donor ligands with the methimazolyl group 
(1-methylimidazolyl-2-thione) and its derivatives as the donor heterocycles, [HB(methimazolyl)3]
-
 (Tm), has 
been developed based upon a similar synthetic methodology (Scheme 1).
[5]
 
 
Scheme 1. The synthesis of hydrotris(azolyl)borate ligands from a BH4
-
 salt and the structure of their 
complexes. 
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The Tm ligand system provides an interesting alternative ligand topology to that provided by the Tp ligands. 
The presence of an extra atom in each arm of the tripod provides a system which forms a bicylo[3.3.3] cage 
on 3-coordination to a metal ion, and this contrasts with the bicyclo[2.2.2] cage present in Tp ligand 
complexes. Thus, while the latter forms a C3v symmetric TpM cage structure containing 6-membered rings, 
angle strain within the 8-membered rings contained within the TmM cage results in a twisted C3-symmetric, 
and consequently chiral, structure (Scheme 1).
[6]
 Our interest in directing this chirality, with a view to 
exploiting Tm complexes in asymmetric catalysis, prompted our exploration of routes to 
tris(methimazolyl)borate ligands which will allow the introduction of chiral groups in place of the 
methimazolyl N-methyl groups. However, we have found that, although reaction of 2-mercapto-1-
benzylimidazole with tetrahydroborate salts successfully provides the corresponding Tm
Bn 
ligand in a melt 
reaction,
[7]
 the chiral 2-mercapto-1-(s-)-methylbenzylimidazole does not undergo a similar reaction, a result 
which we must attribute to the increased steric bulk resulting from the introduction of the -methyl group.[8]  
An alternative, and possibly preferable, route for the introduction of chirality into the Tm ligand is to replace 
the remaining B-H hydride with a chiral group. Our initial approach to this goal involved the use of (Ipc)BCl2 
(Ipc = isopinocampheyl) as the boron precursor, and while its reaction with pyrazolyl sodium successfully 
provided the [(Ipc)B(pz)3]
- 
ligand, treatment with methimazolyl sodium resulted in the formation of the parent 
Tm ligand through dehydroboration of the Ipc group and elimination of pinene. Reaction of [(Ipc)BH3]
-
 with 
methimazole also provided the Tm ligand.
[9]
 As a consequence of these failures of the known routes to 
tris(azolyl)borates to provide our desired chiral Tm derivatives we have explored routes starting from an 
alternative boron precursor. 
In 1981 Niedenzu reported that tris(dimethylamino)borane, B(NMe2)3, provides the dimethylamino aduct of 
tris(pyrazolyl)borane, [(HNMe2)B(pz)3],
[10]
 on reaction with pyrazole, and we found that a similar adduct, 
[(HMe2N)B(methimazolyl)3] (1a), is formed in its reaction with methimazole (Scheme 2a).
[11] 
This prompted 
us to further explore the reactivity of B(NMe2)3 with a range of azole heterocycles. We found that with more 
basic heterocycles, such as imidazole, an alternative type of product is formed in which the dimethyl amine is 
replaced by imidazole, [(imidazole)B(imidazolyl)3] (2) (Scheme 2b). Furthermore, this product is formed no 
matter what the reaction stoichiometry. At this time we interpreted these observations in terms of the 
operation of two alternative mechanisms for the reaction between B(NMe2)3 and azoles dependent upon the 
azole basicity.
[11]
 We have since revised our views on this and report here evidence for an alternative view of 
the formation of the species [(donor)B(azolyl)3] which opens up a very flexible route to a wide range of 
tripodal ligands of this type. Never-the-less, a review of our earlier interpretation of the process will place the 
current work into context. 
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Scheme 2. The previously postulated mechanisms accounting for the formation of different products on 
reaction of B(NMe2)3 with azoles of differing basicity: (a) azoles with basic pKa < 3.5; (b) azoles with basic 
pKa > 3.5 as exemplified by methimazole and imidazole respectively. 
 
In contrast to its pyramidal group 15 analogues E(NMe2)3 (E = As, Sb) which are very strongly basic systems 
capable, for example, of doubly metallating primary amines through transamination,
[12]
 the planar B(NMe2)3 is 
a relatively weak base due to the involvement of the nitrogen lone pairs in B-N -bonding. A further 
consequence of this -bonding is the low Lewis acidity of the boron center. Consequently, we argued that in 
its reactions with weakly basic azoles such as pyrazole (basic pKa = 2.5)
[13]
 and methimazole (basic pKa = -
1)
[14] 
there is no coordination of the heterocycle to the boron and the reaction proceeds via direct 
transamination steps to provide 1a; the initial transamination to provide 4a would be slow due to the low 
basicity of B(NMe2)3 (Scheme 2a). The formation of the alternative species of the type represented by 
[(imidazole)B(imidazolyl)3] (2) from azoles with a basic pKa higher than ca. 3.5, lead us to suggest that a 
preliminary coordination to the boron occurs providing a tetrahedral reactive intermediate [(azole)B(NMe2)3] 
(3), formally isoelectronic with the group 15 E(NMe2)3 species. The greatly increased basicity of this system, 
resulting from the boron rehybridization from sp
2
 to sp
3
, and consequent removal of the B-N -bonding, 
would result in rapid transamination with the remaining azole present in the reaction solution providing 
[(azole)B(azolyl)3] as the ultimate product (Scheme 2b). The reactions are conveniently conducted in toluene 
solution under reflux where the product precipitates from solution in high yield on completion and may be 
monitored by detection of HNMe2 gas released by the reaction. Indeed, the loss of HNMe2 from the reaction 
will shift the equilibrium for what may otherwise be rather thermodynamically unfavourable transamination 
processes.  
Whilst the synthesis of hydrotris(pyrazolyl)borate (Tp) and hydrotris(methimazolyl)borate (Tm) ligands 
starting from a tetrahydroborate salt has proved to be quite flexible, there are a number of factors which limit 
its use for the synthesis of ligands containing alternative azolyl donor groups. For the melt reaction the 
melting point of the azole heterocycle must be considered, and those which readily sublime can cause 
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problems in the synthesis. The acidity of the azole is also a factor; the less acidic systems either not reacting 
with tetrahydroborate or the reaction not progressing to the desired trisubstituted product. The derivatization 
of the ligands by replacing the remaining boron-bound hydride with alternative groups cannot be achieved by 
simple substitution; this B-H group displaying no acidity and only very limited basicity. Although the 
extended high temperature melt reaction of alkali metal tetrahydroborate salts with pyrazole provides the 
tetrakis(pyrazolyl)borate system [B(pz)4]
-
,
[1]
 the substitution of the remaining B-H group in [HB(azolyl)3]
-
 
systems has not been otherwise achieved in a controlled fashion. The preparation of such substituted ligands 
requires the use of [RBH3]
-
 salts or RB(OR)2 systems. Such ligands have attracted increasing attention and the 
replacement of the remaining B-H with an alternative group has been shown to provide ligands which differ 
substantially from the parent Tp ligand in their steric and electronic properties.
[2]
  
We have previously reported that the reactivity of B(NMe2)3 with imidazole described above may be adapted 
to provide a convenient and high yielding one-pot synthesis of [(N-methylimidazole)B(methimazolyl)3] from 
a mixture of B(NMe2)3, methimazole and N-methylimidazole (Scheme 3).
[11]
 There is clearly scope for 
variation in this strategy to provide a wide variety of ligands; indeed we have already reported the synthesis of 
one of our target ligands containing homotopic -methylbenzyl groups in place of the methimazole N-methyl 
groups. The pseudo-C3-symmetric complex of this ligand, [{(N-methylimidazole)B(1-(S-)-methylbenzyl-2-
mercapto-imidazolyl)3}Ru(p-cymene)]
2+
 forms on reaction with [RuCl2(p-cymene)]2 as a single diastereomer 
with the twist of the bicyclo[3.3.3] metal-ligand cage adopting only the  conformation.[8] As discussed 
above, this heterocycle failed to react with [BH4]
- 
and this therefore provides an encouraging indication of the 
flexibility of the new synthetic route. We describe here our further exploration of the scope of this synthetic 
methodology and the resulting reinterpretation of the mechanism of the reaction of azoles with B(NMe2)3. The 
donor properties of the charge neutral [(N-donor)B(methimazolyl)3] and [(N-donor)B(pyrazolyl)3] ligands in 
comparison to their anionic Tm and Tp analogues are also explored. 
 
 
 
 
Scheme 3. The ‘one-pot’ synthesis of ligand 1d. 
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Results and Discussion 
Mechanism of ligand formation 
In our previous work we had concluded that an imine base with a basic pKa of >3.5 is required to coordinate 
to B(NMe2)3 and provide the reactive intermediates 3 (Scheme 4).
[11]
 A number of bases were therefore 
selected (Table 1) and employed in the reaction with B(NMe2)3 and methimazole (1:1:3 stoichiometry) under 
reflux in toluene which provided the products (1) as colorless precipitates on completion of the reaction 
(Scheme 4). Attempts to observe the reactive intermediates 3 in mixtures of B(NMe2)3 and the bases by NMR 
at ambient temperatures provided spectra consistent only with mixtures of the two components, even for the 
strongest base examined (DBU), and we therefore concluded that the equilibrium concentration of the adducts 
(Base)B(NMe2)3 is insufficient to be observed spectroscopically, and thus that K1 is small. It was noted 
however that increased basicity resulted in increased rates of reaction, as measured by the time taken for 
cessation of the evolution of HNMe2 from the reaction mixture (Table 1). In our original interpretation of the 
mechanism this could be explained either by increased basicity of the NMe2 groups in the adducts 3, or by 
higher values of the equilibrium constant K1, as the basicity of the ‘activator’ is increased, or a combination of 
the two. Triethylamine was included in the series to examine whether tertiary amines of suitable basicity could 
be employed in place of heterocyclic imines, however it was found that its use provided only the 
dimethylamine adduct 1a and we therefore concluded that the steric bulk of NEt3 prevents its coordination to 
B(NMe2)3. 
 
Added Base 
Basic pKa 
(MeCN)
[a][15] 
Reaction time 
/h 
Isolated 
Yield 
Ligand 
None - 2 82% 1a 
4-methoxypyridine 14.23 8 85% 1b 
4-N,N-dimethyl-aminopyridine 
(DMAP) 
17.95 6 87% 1c 
1-Methylimidazole Not available
[b] 
3 88% 1d 
Triethylamine 18.4 - - - 
1,5-diazabicyclo-[4.3.0]non-5-ene 
(DBN) 
23.79
[16]
 1 72% 1e 
1,8-Diazabicyclo-[5.4.0]undec-7-ene 
(DBU) 
24.34 1 92% 1f 
[a] The basic pKa is defined as the pKa of the conjugate acid of the base, that of [HPy]
+
 for pyridine for 
example, and is therefore a measure of its Brönsted basicity. T. Rodima, I. Kaljurand, A. Pihl, V. Mäemets, 
I. Leito, I. A. Koppel, J. Org. Chem., 2002, 67, 1873.  
[b] Unfortunately the basic pKa of N-methylimidazole in MeCN appears not to have been reported. 
Table 1. Correlation of added base pKa and reaction time for the synthesis of the ligands 1. 
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Scheme 4. Previously assumed mechanism for the formation of the ligands 1 via the reactive intermediate 3. 
 
Under the same toluene reflux reaction conditions the reaction between B(NMe2)3 and methimazole in the 
absence of an added base provides the dimethylamine adduct 1a, a reaction which requires only 2 hours for 
completion. It was therefore surprising that, for the reactions with added bases which require longer periods 
than this, the products 1b-d are not contaminated with 1a which, in the absence of the added base, is formed 
more quickly. Given our failure to observe the adducts 3 in mixtures of B(NMe2)3 and the activating bases, 
this cannot be due to the absence of B(NMe2)3 in the reaction solutions. The explanation must lie in the details 
of the reaction between methimazole and the boron-bound NMe2 groups (Scheme 5). In the absence of the 
added base it is reasonable to postulate progress of the reaction via the intermediate 4a and subsequently 
through sequential transamination of the remaining two NMe2 groups to provide 1a. However, in the reactions 
containing an added base the products 1b-f may be formed via the intermediates 5b-f, which are those 
previously proposed to be formed via the intermediates 3, but which may also be accessible from 4a through 
an HNMe2/base exchange with its associated equilibrium constant K2. This equilibrium would be driven 
towards 5b-f by the volatility of HNMe2 which would readily be lost from the toluene solution under reflux. 
Since the intermediate 4a cannot be isolated, whether the HNMe2 group in this species can be substituted by 
an added base cannot be proved. However, we find that reaction of DMAP with 1a in toluene under reflux 
does result in substitution to provide [(DMAP)B(methimazolyl)3] (1c), thus establishing that the formation of 
ligands 1b-f does not require the previously suggested intermediacy of the B(NMe2)3 adducts 3. The 
correlation of reaction time with the pKa of the added base (Table 1) reflects the significance of this factor in 
determining the rate of HNMe2 substitution. The non-aqueous (MeCN) pKa of HNMe2, which is required to 
compare with the other bases studied on a consistent basis, has not been reported; the most closely related 
secondary amine to have its pKa determined in this solvent is HNMePr which has a value of 18.92.
[17]
 
Accepting that this will be close to that for HNMe2, the fact that it can be substituted by weaker bases (Table 
1) which presumably bind less strongly to boron,
[18]
 must reflect a shifting of the substitution equilibrium due 
to the loss of HNMe2 gas from the reaction. The duration of the reactions has been determined by monitoring 
the evolution of HNMe2 and thus, although the formation of 1a may be complete in 2 h, the liberation of the 
free amine will continue until the formation of the final products 1b-f is complete. 
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Scheme 5. Mechanism for the formation of the ligands 1 via substitution of HNMe2 at boron by an added 
base.  
 
The above discussion presupposes that the substitution of HNMe2 does not occur until the species 1a is 
formed.  Whether this is the case or the substitution occurs from a species with one (4a) or two (6a) 
methimazolyl groups is perhaps a moot point; however it is possible to speculate about the most likely stage at 
which the substitution occurs. Studies on the substitution of Lewis base adducts of boron derivatives suggest 
that both SN1 and SN2 pathways may be involved in such processes.
[19]
  Given the B-N -bonding which will 
stabilise the boranes produced on dissociation of HNMe2 from 4a, and to a lesser extent 6a, and the combined 
steric bulk of the groups attached to boron in 1a, SN1 processes would seem most likely to be operating in this 
system. Given this, the availability of two NMe2 groups in 4a to provide stabilisation of the trigonal borane 
intermediate via B-N - interactions would make this the most likely stage at which substitution occurs. The 
fact that the reactions with the very strongly basic DBN and DBU are complete to form 1e and 1f in 1 h (faster 
than the formation of 1a in the absence of an added base) indicates that this substitution of HNMe2 must be 
occurring at an early stage of the reaction. For the weaker bases, which form their products (1b-d) more 
slowly than 1a is formed, it seems that the transamination steps with methimazole compete with the HNMe2 
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substitution in 4a such that at least a proportion of the final products are formed via 1a, thus accounting for 
the correlation between the reaction duration and basicity in these cases.  
These observations provide a potentially very flexible route to new ligands by substitution of the HNMe2 in 
[(HNMe2)B(methimazolyl)3] (1a). To establish the general applicability of this route we have synthesised the 
ligands 1c-e (Scheme 4 and Table 1) by treatment of 1a with the selected base in toluene under reflux 
(Scheme 6). We have no reason to suspect that this route will not succeed for any ligand which may be 
synthesised via the ‘one-pot’ route, as would be anticipated from our foregoing discussion of the mechanism. 
We have further extended this synthesis to incorporate chiral bases into the ligand and details of this work will 
appear in a subsequent publication.  
 
 
 
Scheme 6. Substitution of HNMe2 in 1a by added bases to form the ligands 1c-e. 
 
 
A ruthenium
II
 complex of ligand 1e 
A Ru
II
 complex of the ligand 1e containing DBN coordinated to boron was synthesised by reaction with the 
dimer [(p-cymene)RuCl2]2 in ethanol. The resulting chloride salt of the complex was then treated with NH4PF6 
to provide [{3-(DBN)B(methimazolyl)3}Ru(p-cymene)][PF6]2 (8). The positive ion FAB mass spectrum of 
this complex shows an ion at M/z = 501.9 corresponding to M
+
/2; the 
1
H and 
13
C NMR spectra are consistent 
with the anticipated structure showing signals for the p-cymene, DBN and methimazolyl components. The X-
ray crystal structure of the salt was determined and the structure of the dicationic complex is shown in Figure 
1. Selected bond-distances and angles are provided in Table 2. The ligand 1e is 3-S,S,S-coordinated to the 
ruthenium center. There are 4 molecules in the unit cell related pairwise by inversion centres and these 
therefore represent the two enantiomeric  and  forms of the C3-symmetric metal-ligand bicyclo[3.3.3] 
cage structure. The coordinate B-N bond to the DBN [1.569(6) Å] is marginally longer than those to the 
covalently bound methimazolyl nitrogen atoms [range 1.538(5) – 1.561(4) Å], a feature we have found to be 
common to these types of ligand. The three contiguous carbon atoms in the 6-membered ring of the DBN and 
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their attached hydrogen atoms are disordered over two sites representing the presence of this ring in two 
different conformations. We have previously noted the flexibility of the C-S-M angles in Tm metal complexes 
manifest in the variability of these angles in different complexes. The structures of many Tm metal complexes 
are constrained by crystallographically imposed 3-fold symmetry and in these all three such angles are thus 
equivalent, however this is not possible when the boron bound hydride in Tm is replaced by a donor such as 
DBN. In the structure of 8 the C-S-Ru angles range from 114.23(11) to 100.14(11)º representing a substantial 
distortion of the metal-ligand cage structure. This range may be compared with those in [(Tm)Ru(p-cymene)]
+
 
[108.34(10) – 113.33(10)º][20] and [(TmEt)Ru(p-cymene)]+ [108.41(9) – 110.68(10)º].[6] The 14º range found 
for the C-S-Ru angles thus appears to be exceptionally large in 8 and it is a further illustration of the 
substantial flexibility of the M-S coordination geometry in these ligands which we have discussed 
previously.
[6] 
 
 
 
Table 2. Selected bond lengths (Å) and angles (º) for [(DBN)B(methimazolyl)3}Ru(p-cymene)][PF6]2 (8) 
[{(DMAP)B(pz)3}Ru(p-cymene)Cl][PF6] (11), [{(N-methyl-imidazole)B(methimazolyl)3}Mn(CO)3][PF6] (12) 
and [{(N-methylimidazole)B(pyrazolyl)3}Mn(CO)3][PF6] (13). 
8 11 12 13 
Ru-S(1) 2.4540(9) Ru(1)-N(11A) 2.076(2) Mn(1)-S(11) 2.4327(16) Mn(1)-N(21) 2.053(4) 
Ru-S(2) 2.4031(9) Ru(1)-N(16A) 2.086(2) Mn(1)-S(12) 2.4138(16) Mn(1)-N(22) 2.051(4) 
Ru-S(3) 2.4256(8) Ru(1)-Cl(1C) 2.3908(7) Mn(1)-S(13) 2.4603(16) Mn(1)-N(23) 2.035(4) 
B-N(11)1.553(4) N(7A)-B(10A) 1.569(3) B(1)-N(31) 1.535(8) N(11)-B(1) 1.543(6) 
B-N(12) 1.561(4) B(10A)-N(21A) 1.521(4) B(1)-N(32) 1.542(7) N(12)-B(1) 1.538(6) 
B-N(13) 1.538(5) B(10A)-N(12A) 1.531(4) B(1)-N(33) 1.548(7) N(13)-B(1) 1.544(6) 
B-N(14) 1.569(5) B(10A)-N(17A) 1.540(4) B(1)-N(14) 1.591(7) N(14)-B(1) 1.543(6) 
S(2)-Ru(1)-S(3) 
87.08(3) 
N(21A)-B(10A)-N(12A) 
111.9(2) 
S(11)-Mn(1)-S(12) 
91.11(5) 
N(21)-Mn(1)-N(22) 
85.97(16) 
S(2)-Ru(1)-S(1) 
90.90(3) 
N(21A)-B(10A)-N(17A) 
109.7(2) 
S(11)-Mn(1)-S(13) 
93.53(5) 
N(21)-Mn(1)-N(23) 
84.77(15) 
S(3)-Ru(1)-S(1) 
95.69(3) 
N(12A)-B(10A)-N(17A) 
111.4(2) 
S(12)-Mn(1)-S(13) 
93.22(5) 
N(22)-Mn(1)-N(23) 
85.71(16)  
N(13)-B(1)-N(11) 
109.6(3) 
N(21A)-B(10A)-N(7A) 
110.4(2) 
N(31)-B(1)-N(32) 
115.0(4) 
N(13)-B(1)-N(14) 
104.4(4) 
N(13)-B(1)-N(12) 
116.7(3) 
N(12A)-B(10A)-N(7A) 
105.9(2) 
N(31)-B(1)-N(33) 
113.0(4) 
N(13)-B(1)-N(11) 
108.2(3) 
N(11)-B(1)-N(12) 
105.0(3) 
N(17A)-B(10A)-N(7A) 
107.4(2) 
N(32)-B(1)-N(33) 
108.0(4) 
N(14)-B(1)-N(11) 
116.4(4) 
N(13)-B(1)-N(14) 
104.5(3) 
N(11A)-Ru(1)-N(16A) 
86.75(8) 
N(31)-B(1)-N(14) 
103.3(4) 
N(13)-B(1)-N(12) 
108.9(4) 
N(11)-B(1)-N(14) 
111.5(3) 
 
N(32)-B(1)-N(14) 
108.5(4) 
N(14)-B(1)-N(12) 
110.6(4) 
N(12)-B(1)-N(14) 
109.6(3) 
 
N(33)-B(1)-N(14) 
108.9(4) 
N(11)-B(1)-N(12) 
108.0(3) 
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Figure 1. Structure of the dication in [{3-(DBN)B(methimazolyl)3}Ru(p-cymene)][PF6]2 (8). PF6
-
 
counterions not shown. Selected bond lengths and angles are provided in Table 2. 
 
Tris(pyrazolyl)borate ligands 
The possibility that this synthetic method may be employed for the preparation of analogous 
tris(pyrazolyl)borate ligands has also been explored. The substantial literature concerning the chemistry and 
applications of tris(pyrazolyl)borate ligands and their various derivatives attests to their significance in 
coordination chemistry, catalysis and a variety of other fields.
[2]
 A flexible route to their boron substituted 
derivatives would provide a potentially valuable new addition to the synthetic toolkit available for the design 
of such ligands for specific applications. The required precursor for this study [(HNMe2)B(pz)3] (9) is readily 
available by reaction of B(NMe2)3 with pyrazole according to the procedure developed by Niedenzu.
[10]
 
Reaction of 9 with both 1-methylimidazole and DMAP proceeds smoothly under reflux in toluene to liberate 
HNMe2 and provide the new ligands (10a and 10b) in very high yield (Scheme 7). 
 
 
Scheme 7. Substitution of HNMe2 in 9 by added bases to form the new ligands 10a and 10b. 
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To establish the coordination chemistry of these new ligands 10b was reacted with the dimer [(p-
cymene)RuCl2]2 in methanol solution followed by salt metathesis with NH4PF6 to provide the yellow salt 11. 
We anticipated the formation of the complex [{3-(DMAP)B(pz)3}Ru(p-cymene)][PF6]2; however, the +FAB 
mass spectrum of 11 showed a molecular ion at m/z = 605 consistent with the formulation [{2-
(DMAP)B(pz)3}RuCl(p-cymene)]
+
 indicating that the ligand adopts a 2-N,N-coordination mode and one 
chloride remains coordinated to ruthenium. 
1
H and 
13
C nmr spectra of 11 are consistent with this and show 
signals due to two different pyrazolyl ring environments (2:1 ratio). The X-ray crystal structure of 11 was 
obtained and the structure of the cationic complex is shown in Figure 2. The structure found confirms the 
observations from the mass and nmr spectra; the ligand coordinates to ruthenium through two of its pyrazolyl 
rings and the third remains uncoordinated. The retention of the chloride ligand at ruthenium results in the 
coordination of the ligand in such a way that the uncoordinated pyrazolyl ring is orientated away from the 
metal. This structure is similar to that of [{2-HB(pz)3}RuCl(arene)] which may be isolated from the reaction 
of NaTp with [(arene)RuCl2]2 (arene = p-xylene, mesitylene, hexamethylbenzene) in MeCN.
[21]
 The Ru-N 
bond distances to the two coordinated pyrazolyl rings are very similar [2.086(2) and 2.076(2) Å] and compare 
with values of 2.081(5) and 2.083(5) Å in [{2-HB(pz)3}RuCl-(hexamethylbenzene)]. The Ru-Cl distances in 
these two complexes are also very similar at 2.3908(7) Å in 11 and 2.397(2) Å in the Tp complex.  
 
 
Figure 2. Structure of the cation in [{2-(DMAP)B(pz)3}RuCl(p-cymene)][PF6] (11). PF6
-
 counterion not 
shown. Selected bond lengths and angles are provided in Table 2. 
 
Donor Properties of the Ligands  
Wishing to be able to compare the donor properties of the ligands 1, [(Base)B(methimazolyl)3] and 10, 
[(Base)B(pyrazolyl)3] with their anionic hydrotris(azolyl)borate counterparts (Tp and Tm) we have 
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synthesised manganese tricarbonyl complexes of the ligands, [(1-methylimidazole)B(methimazolyl)3] (1d) 
and [(1-methylimidazole)B(pyrazolyl)3] (10a) by treatment with [Mn(CO)3(NCMe)3][PF6] in MeCN solution. 
These reactions proceed smoothly to provide the salts [{(1-
methylimidazole)B(methimazolyl)3}Mn(CO)3][PF6] (12) and [{(1-
methylimidazole)B(pyrazolyl)3}Mn(CO)3][PF6] (13) in high yield. Spectroscopic characterisation of these 
complexes is consistent with 3-S,S,S and 3-N,N,N coordination of the ligands in 12 and 13 respectively and 
this is confirmed by X-ray crystallography. The structure of the cation in 12 is shown in Figure 3 and that in 
13 in Figure 4. Selected bond-distances and angles are provided in Table 2. 
Describing the structure of complex (12) containing the methimazolyl donor ligand first; the crystals contain 
two molecules per unit cell related by an inversion centre, and these therefore represent the  and  
enantiomeric forms of the complex in which the C3-symmetric twist of the metal-ligand cage adopts either a 
left or right handed twist. We have previously published the structure of the analogous charge-neutral 
Mn(CO)3 complex containing the anionic hydrotris(methimazolyl)borate (Tm) ligand, [(Tm)Mn(CO)3] (14), 
in which the 1-methylimidazole of 12 is replaced by a hydride on boron. For the purposes of comparing the 
characteristics of the two ligands it is useful to compare the bond lengths and angles in the two complexes, 
however, this is complicated by the fact that there are two independent molecules in the unit cell of 14 which 
differ substantially in their metrical parameters. For the purposes of this comparison therefore, the mean 
values for the data for this complex will be used. In 12 the mean Mn-S distance is 2.4356 Å (esds of 
individual values = 0.0016) while in 14 the corresponding mean is 2.4146 Å (esds of individual values = 
0.0005), a difference of 0.021 Å. While this might be interpreted as weaker S-Mn interactions in 12, it has 
previously been noted that M-S bond lengths in Tm complexes may vary substantially in closely related 
systems.
[6]
 This is best illustrated by the fact that in the two independent molecules present in the crystal of 14 
the mean Mn-S distances are 2.4015 and 2.4277 Å (esds as above), a difference of 0.0262 Å. Similarly, in the 
complexes [(Tm)Cu(PAr3)] (Ar = Ph, m-tolyl, p-tolyl) the mean Cu-S distances differ by 0.055 Å, a variation 
which is not correlated with the steric bulk or donor properties of the phosphine ligands.
[22]
 Consequently 
caution is required in interpreting M-S bond distances in Tm and related complexes in terms of the donor 
properties of the ligands and a more reliable comparison is provided by the energy of the CO stretching 
vibrations (vide infra). 
Page 13 of 25 
 
Figure 3. Structure of the cation in [{(1-methylimidazole)B(methimazolyl)3}Mn(CO)3][PF6] (12). PF6
-
 
counterion not shown. Selected bond lengths and angles are provided in Table 2. 
 
 
Figure 4. Structure of the cation in [{(1-methylimidazole)B(pyrazolyl)3}Mn(CO)3][PF6] (13). PF6
-
 counterion 
not shown. Selected bond lengths and angles are provided in Table 2. 
 
Given the replacement of H
-
 in 14 by 1-methylimidazole in 12 the other bonds which are worthy of 
comparison between these two complexes are the B-N distances to the methimazolyl rings. In 14 the mean 
distance for the two independent molecules is 1.5501 Å (individual esds = 0.0017) while in 12 the mean is 
1.542 Å (max. individual esds = 0.008) and the two values are not therefore crystallographically 
distinguishable. The B-N distance to the N-methylimidazole in 12 is 1.591(7) Å, slightly longer than the 
Page 14 of 25 
distances to the methimazole nitrogen atoms. It may be concluded from these data that the replacement of the 
hydride in 14 by N-methylimidazole in 12, and the resulting change in ligand charge, does not have a 
significant effect on the bond distances to the methimazolyl nitrogen atoms. This may be rationalised by the 
ability of the imidazole to stabilise a positive charge, and there is thus little difference between the boron 
centred charge in the two ligands (Figure 5). On this basis it might be anticipated that there should be little 
difference between the sulfur donor properties of the two ligands. 
 
 
 
Figure 5. Location of charge in the Tm ligand and its neutral analogue, ligand 1d. 
 
The 1-methylimidazole in [{(1-methylimidazole)B(pz)3}-Mn(CO)3][PF6] (13) is disordered over two sites 
approximately related by a 90º rotation about the B-N axis. One carbon atom in the ring is common to both 
sites, as is the methyl carbon. The mean Mn-N distance in 13 is 2.046 Å (individual esds = 0.004) while that 
in the two independent molecules present in the unit cell of [(Tp)Mn(CO)3] (15) is 2.070 Å; however, this 
disguises the fact that the mean Mn-N bond distances in the two molecules of 15 in the unit cell are 2.177 and 
1.963 Å and it is not therefore reasonable to interpret the differences between the mean values for 13 and 15 in 
terms of the donor properties of the pz rings in the two ligands. Again, a better measure is available from a 
comparison of the CO stretching energies. The mean B-N(pz) distance in 13 is 1.542 Å (individual esds = 
0.006) which is indistinguishable from the value of 1.541 Å in 15.  
The overall picture which emerges from the structural comparison of the these complexes is one in which the 
variation between bond lengths in complexes of Tm and Tp complexes (even between the same complexes 
within unit cells of crystals) is too large to be able to distinguish any pattern of variation in comparison with 
their analogues containing the N-methylimidazole substituted ligands 1d and 10a. Thus, there is no structural 
evidence for differences in donor properties between the anionic Tm and Tp ligands and the charge neutral 1d 
and 10a. Fortunately there is a much more sensitive means of assessing the donor properties of ligands.  
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It has become common practice to compare the donor properties of ligands by indirectly sensing the 
donor/acceptor properties of the coordinated metal via the CO stretching energies of attached carbonyl 
ligands. This provides a sensitive measure of the ability of the metal to partake in the acceptor and donor 
interactions with its CO ligands and thus the metal centred electron density provided by the ligands under 
study. In the current context we are fortunate in there being available a wide range of Mn(CO)3 complexes of 
tripodal borate and related ligands to serve as comparators with our new ligands [(1-methylimidazole)-
B(methimazolyl)3] (1d) and [(1-methyl-imidazole)B(pz)3] (10a), and it should therefore be possible to assess 
their donor properties and place them in context with their related ligands. The infra-red data for a selected 
group of complexes along with those for 12 and 13 are provided in Table 3. It is unfortunate that spectra for 
the various complexes are reported in different solvents and only a solid state spectum (KBr) is reported for 
one of the complexes; notwithstanding this however, a consistent picture is provided for the situation as 
discussed below. The energy of the A symmetry (higher energy) C-O vibration mode provides the best 
measure of the C-O bond strength in these complexes, being the simultaneous stretching of all three CO 
ligands, and the energy of this vibration for each complex will therefore be compared as a measure of the 
donor properties of the various ligands. 
 
[a] NMI = 1-methylimidazole 
Table 3. IR data (co) for manganese tricarbonyl complexes bearing tripodal tris(azolyl)-borate and -methane 
ligands. 
 
It should be borne in mind that the new ligands 1d and 10a are charge neutral systems and thus provide 
cationic complexes with the Mn
I
 tricarbonyl unit, while the anionic Tm and Tp ligands and their derivatives 
give neutral complexes. In the absence of other factors the introduction of a positive charge into a carbonyl 
complex will result in an increase in CO stretching energy for the attached carbonyl ligands; in the present 
context this is illustrated by a comparison of the co values for the complexes containing the [HB(pz)3]
- 
(Tp) 
and HC(pz)3 ligands where a difference of 15 cm
-1
 is observed due to the isoelectronic replacement of HB
-
 by 
HC in these species. In light of this the difference of only 5 cm
-1 
between the cationic complex 13, containing 
the neutral ligand [(N-methylimidazole)B(pz)3] (10a), and the neutral Tp complex is worthy of note. A 
Complex
[a] 
co/cm
-1
  Medium Ref 
[{HB(methimazolyl)3}Mn(CO)3] 2003, 1905  Toluene [20] 
[{(NMI)B(methimazolyl)3}Mn(CO)3] [PF6] (12) 2007, 1914  MeCN This work 
[{HB(3,5-Me2Pz)3}Mn(CO)3] 2023, 1912  KBr [23] 
[{HB(pz)3}Mn(CO)3] 2036, 1932  MeCN [24] 
[{pzB(pz)3}Mn(CO)3] 2039, 1936  MeCN [24] 
[{(NMI)B(pz)3}Mn(CO)3][PF6] (13) 2041, 1941  MeCN This work 
[{HC(3,5-Me2pz)3}Mn(CO)3][OTf] 2044, 1949  CH2Cl2 [25] 
[{HC(pz)3}Mn(CO)3][OTf] 2051, 1956  CH2Cl2 [25] 
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comparison between 13 and the similarly cationic complex with the neutral HC(pz)3 ligand shows that the CO 
ligands in 13 vibrate 10 cm
-1
 lower in energy, and even those in the complex with the stronger donor HC(3,5-
Me2pz)3 have an energy which is 3 cm
-1
 higher. On this basis therefore it appears that the donor properties of 
the ligand 10a lies approximately mid way between that of Tp and HC(3,5-Me2pz)3, and is thus a substantially 
stronger donor than might have been predicted at first sight. This may be attributed to the ability of the boron-
bound N-methylimidazole ring to stabilize a positive charge (illustrated for ligand 1d in Figure 5), thus in 
cationic complexes such as those of the Mn(CO)3
+
 unit considered here, the positive charge is substantially 
located remote from the metal. Such a charge localisation is not possible in the tris(pyrazolyl)methane ligands 
and these are therefore effectively weaker donors.  
A similar situation is revealed in the comparison of the complex [{(1-methylimidazole)B(methimazolyl)3} 
Mn(CO)3] [PF6] (12) and its neutral analogue containing the Tm ligand, [{HB(methimazolyl)3}Mn(CO)3]. The 
energy of the A-symmetry co vibration for 12 is only 4 cm
-1
 higher than that for the Tm complex, indicating 
only a slight decrease in donor properties on replacement of H-B
- 
by 
+
N-B
-
 which may again be attributed to 
the localisation of the positive charge within the 1-methylimidazole ring remote from the coordinated metal. 
The tris(methimazolyl)methane ligand has recently been reported,
[26]
 but unfortunately its Mn(CO)3 complex 
has not been prepared and a comparison with this ligand in the present context is therefore not possible.  
 
Conclusions 
The ease with which the HNMe2 may be substituted by alternative N-donors in both 
(HNMe2)B(methimazolyl)3 (1a) and (HNMe2)B(pyrazolyl)3 (9) provides a flexible and high-yielding route to 
new ligands. The extension of this methodology to introduce functionality in this position could lead to a 
range of possibilities for incorporating these tris(azolyl) tripods (and their complexes) into larger systems, by 
incorporation of additional metal-binding or polymerizable groups for example. We are continuing to explore 
the range of donors which may be used to substitute the HNMe2 in these systems.  
 
Experimental Section 
General: All reactions were carried out under an atmosphere of dry, oxygen-free dinitrogen, using standard 
Schlenk techniques. Solvents were distilled and dried by standard methods or used directly from a Glass 
Contour solvent purification system and further degassed before use where necessary. Mass spectra were 
recorded on Kratos MS50TC (FAB) and Micromass Platform II (ES-MS) spectrometers. NMR spectra were 
recorded on a Bruker 250AC spectrometer operating at room temperature. 
1
H and 
13
C chemical shifts are 
reported in ppm relative to SiMe4 ( = 0) and were referenced internally with respect to the protio solvent 
impurity or the 
13
C resonances respectively. Multiplicities and peak types are abbreviated: singlet, s; doublet, 
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d; triplet, t;multiplet, m; broad, br; aromatic, ar. Infra red spectra were recorded from solution using cells with 
CaF2 windows on a Jasco FT-IR 410 spectrometer. The compounds [(HMe2N)B(methimazolyl)3] (1a),
[11]
 
[(HMe2N)B-(pyrazolyl)3],
[10a]
 [(p-cymene)RuCl2]2
[27] 
and [Mn(CO)3(NCMe)3][PF6]
[28]
 were synthesised 
according to the literature procedures.  All other chemicals were obtained from Sigma-Aldrich and used as 
received.  
Synthesis of ligands (Method A): The tris(methimazolyl) ligands were synthesised by two routes. In the ‘one-
pot’ reaction (Method A) B(NMe2)3, methimazole and the added base (1:3:1 stiochiometry) are heated to 
reflux in toluene until evolution of HNMe2 ceases, as judged by testing of the evolved gasses with damp pH 
paper. The duration of the reactions for ligands 1a-f are given in Table 1. The detailed procedure for 1b is 
provided below, others followed a similar protocol. All ligands are colorless solids.  
[(4-methoxypyridine)B(methimazolyl)3] (1b): 4-methoxypyridine (156 l, 1.43 mmol), tris(dimethylamino) 
borane (250 l, 1.43 mmol) and methimazole (0.444 g, 3.90 mmol) were heated to reflux in dry toluene (10 
mL). The evolution of HNMe2 ceased after 8h at which time a colourless solid had formed in the solution. The 
reaction mixture was cooled and the solid product filtered and washed with hexane (2 x 10 mL). Yield 0.506 
g, 1.10 mmol, 85%. 
1
H-NMR (250.1 MHz, CDCl3),  8.62 (br, 2H), 7.01 (t, 1H, J = 1.56 Hz), 6.97 (t, 1H, J = 
1.56 Hz), 6.78 (br, 3H), 6.61 (d, 3H, = 2.34 Hz), 3.95 (s, 3H), 3.47 (s, 9H); 
13
C-NMR (62.9 MHz, CDCl3), 
C=S165.9 (Cquat), 1478.0 (CH), 128.6 (CH), 118.2 (CH), 110.2 (CH), 57.3 (CH3), 35.3 (CH3); 
11
B-
NMR (80.3 MHz, CDCl3), 5.43; MS (EI +25eV): M
+
= 459.88 (M
+
+1); Anal. Calcd for C18H22BN7OS3; C, 
47.06; H, 4,83; N, 21.34. Found: C, 46.87; H, 4,60; N, 21.69.  
[(4-dimethylaminopyridine)B(methimazolyl)3] (1c): Yield 87%. 
1
H-NMR (250.1 MHz, CDCl3),  8.12 (br, 
2H), 6.59 (d, 3H, J= 2.34 Hz), 6.54 (t, 1H, J= 1.43 Hz), 6.51 (t, 1H, J= 1.43 Hz), 3.48 (s, 9H), 3.09 (s, 6H); 
13
C-NMR (62.9 MHz, CDCl3), 165.77 (C=S), 156.7 (Cquat); 146.6 (CH), 123.1 (CH), 117.9 (CH), 105.9 
(CH), 40.1 (CH3), 35.2 (CH3); 
11
B-NMR (80.3 MHz, CDCl3), 5.08; MS (EI +25eV): M
+
= 473.04; Anal. 
Calcd for C19H25BN8S3B; C, 48.30; H, 5.33; N, 23.72. Anal. Calcd for C19H25BN8S3; C, 48.30; H, 5.33; N, 
23.72. Found: C, 48.09; H, 5.10; N, 23.91.  
[(N-methylimidazole)B(methimazolyl)3] (1d): Yield 88%. 
1
H-NMR (250.1 MHz, CDCl3), : 3.49 (s, 9H), 
3.81 (s, 3H), 6.61-6.65 (m, 6H), 6.95 (s, 1H), 7.19 (s, 1H), 8.97 (s, 1H); 
13
C-NMR (62.9 MHz, CDCl3), : 
35.10 (CH3met), 36.05 (CH3Imi), 114.36 (CHImi), 117.9 (CHmet), 121.6 (CHImi), 124.6 (CHMet), 142.7 
(CHImi), 164.7 (C=S); 
11
B-NMR (80.3 MHz, CDCl3), : 8.05; MS (EI +25eV): M
+
= 433; Anal. Calcd for 
C16H21BN8S3
.
C7H8; C, 52.66; H, 5.57; N, 21.36. Found: C, 52.57; H, 5.52; N, 21.39.  
[(DBN)B(methimazolyl)3] (1e): Yield 72%. 
1
H nmr (500.1 MHz, CDCl3): δH 6.71 (3H, d J = 2.5 Hz), 6.67 
(3H, d, J = 2.2 Hz), 6.6-6.5 (2H, m), 3.6 (9H, s), 3.56-3.49 (6H, m), 3.39-3.33 (2H, m), 2.05-1.9 (2H, br); 
13
C 
nmr (90.5 MHz, DMSO): δC 161.0 (C=S), 129.3 (Cq DBN), 120.1 (CHmet), 114.1 (CHmet), 46.9 (CH2DBN), 43.9 
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(CH2DBN), 42.9 (CH2DBN), 34.9 (CH2DBN), 30.7 (CH2DBN), 24.1 (CH3met), 18.3 (CH2DBN); MS (FAB
+
): m/z = 
474.6; Anal. Calcd. for C19H27BN8S3 (474.16): C, 48.10; H, 5.74; N, 23.61; found: C, 47.60; H, 5.46; N, 23.36 
%.  
[(DBU)B(methimazolyl)3] (1f): Recrystallised from MeOH. Yield 92%.
1
H-NMR (250.1 MHz, DMSO-d6), 
7.10 (d, 3H, J = 2.34Hz), 6.79 (d, 3H, J = 2.34Hz), 4.15 (m, 2H), 3.88 (m, 2H), 3.54 (s, 9H), 2,33 (m, 2H), 
1.93 (m, 2H), 1.73 (m, 2H), 1.70 (m, 2H), 1.10 (m, 4H); 
13
C-NMR (62.9 MHz, DMSO-d6), 165.70 
(CquatDBU), 161.4 (C=S); 119.8 (CHmet), 114.6 (CHmet), 55.4 (CH2DBU) 53.7 (CH2DBU) 48.3 (CH2DBU) 33.9 
(CH3met), 31.7 (CH2DBU) 28.7 (CH2DBU) 26.4 (CH2DBU) 23.8 (CH2DBU) 19.4 (CH2DBU); 
11
B-NMR (80.3 MHz, 
DMSO-d6), 7.57; MS (EI +25eV): M
+
= 503.05, 389.07 (M-het); Anal. Calcd for C21H31BN8S3B
.
MeOH; C, 
49.43; H, 6.60; N, 20.96. Found: C, 49.22; H, 6.42; N, 21.54. 
Method B of ligand synthesis involves substitution of HNMe2 in [(HNMe2)B(azolyl)3] (azolyl = 
methimazolyl, pyrazolyl). The procedure for ligand 1c is given below and the other ligands followed a similar 
protocol.  
[(4-dimethylaminopyridine)B(methimazolyl)3] (1c): To a solution of 4-dimethylaminopyridine (62 mg, 0.506 
mmol) in toluene (15 mL) was added [(HNMe2)B(methimazolyl)3] (1a) (200 mg, 0.506 mmol). The mixture 
was heated under reflux for 4 h with the solution becoming cloudy after 2 h. After cooling the solid product 
was isolated by filtration and washed with diethyl ether (3 x 5 mL) Yield 181 mg of 1c (76%) as a colorless 
powder. 
[(DBN)B(methimazolyl)3}Ru(p-cymene)][PF6]2 (8): [Ru(p-cymene)Cl2]2 (64.6 mg, 0.105 mmol) was 
dissolved in ethanol (15 mL) and stirred at room temperature for 45 minutes. The ligand 1e (100 mg, 0.210 
mmol) was added as a solid in small portions and the mixture stirred for 12 h at room temperature. After this 
period NH4PF6 (171 mg, 1.05 mmol) was added and the precipitation of an orange solid was observed. After 
filtration by cannula, the solid was washed with ethanol (3 x 7 mL) and then with diethyl ether (2 x 5mL). 
Drying under vacuum provided 171 mg of 8 (76%). Crystals suitable for X-ray were obtained by slow 
diffusion of diethyl ether in a concentrated solution of the complex in acetonitrile. δH (250.1 MHz, CD3CN): 
7.15 (3H, d, J=3.0 Hz), 6.77 (3H , d, J=3.1 Hz,), 5.53-5.39 (4H, m), 3.91 (1H, sept, J=6.7 Hz), 3.77-3.71 (2H, 
m), 3.67 (9H, s),  
3.64-3.39 (4H, m), 2.47-2.38 (2H, m), 2.18 (3H, s), 1.30 (2H, m), 1.17 ppm (6H, t, J=7 Hz); δC (125.7 MHz, 
(CH3)2CO): 172.2 (Cq DBN), 148.9 (Cq met), 124.4 (CH met), 124.1(CH met), 107.8 (Cq p-cym), 103.5 (Cq p-cym), 87.3 
(2CH p-cym), 86.3 (CH p-cym), 85.3 (2CH p-cym), 55.3 (CH2 DBN), 46.7 (CH2 DBN), 45.4 (CH2 DBN), 37.1 (CH2 DBN), 
36.9 (CH2 DBN), 32.0 (CH3 met), 23.5 (CH3 p-cym), 21.3 (2CH3 p-cym), 19.5 (CH2 DBN); δB(115.5 MHz, DMSO): 
4.15; MS (FAB
+
): m/z = 501.9 [(M+1)/2]; Anal. Calcd for C29H41BF12N8P2RuS3: C, 34.89; H, 4.13; N, 11.21; 
found: C, 34.16; H, 4.02; N, 11.15%. 
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[(N-methylimidazole)B(pyrazolyl)3] (10a): 92% yield. 
1
H-NMR (250.1 MHz, CDCl3),  8.52 (s, 1H), 7.65 
(dd, 3H, J = 1.56Hz, J = 0.51Hz), 7.48 (t 1H, J = 1.53 Hz), 6.88 (dd, 3H, J = 2.34 Hz, J = 0.51Hz), 6.85 (t 1H, 
J = 1.53 Hz), 6.17 (dd, 3H, J = 2.34Hz, 1.56 Hz), 3.68 (s, 3H); 
13
C-NMR (62.9 MHz, CDCl3), 140.9 
(CHimi), 137.4 (CHimi); 133.6 (CHimi), 125.5 (CHpy), 119.6 (CHpy), 104.1 (CHpy), 34.4 (CH3imi); 
11
B-
NMR (80.3 MHz, CDCl3), 3.76; MS (EI +25eV): M
+
= 295.13 (M+1); Anal. Calcd for C13H15N8B; C, 53.09; 
H, 5.14; N, 38.10. Found: C, 53.24; H, 5.03; N, 38.29. 
[(4-dimethylaminopyridine)B(pyrazolyl)3] (10b): 90% yield. 
1
H nmr (360.1 MHz, CDCl3): δH 8.31 (2H, d, J = 
7.4 Hz), 7.74 (3H, d, J = 0.8 Hz), 7.12 (3H, d, J = 2.2 Hz), 6.56 (2H, d, J = 7.8 Hz), 6.25 (3H, t, J = 1.7 Hz 
and J = 0.9 Hz), 3.16 (6H, s); 
13
C nmr (90.5 MHz, CD3CN): δC 156.1 (Cq DMAP), 145.4 (CH pz), 135.3 (CH pz), 
129.1 (CH DMAP), 106.6 (CH pz), 105.7 (CH DMAP), 39.9 (CH3 DMAP); MS (FAB
+
): m/ z = 335.3 (M+1); 
C16H19BN8: C, 57.50; H, 5.73; N, 33.53; found: C, 57.01; H, 5.39; N, 33.38 %. 
[{(DMAP)B(pz)3}Ru(p-cymene)Cl]PF6 (11): [(p-cymene)-RuCl2]2 (110 mg, 0.0179 mmol) was dissolved in 
methanol (10 mL) and stirred for 1 h. [(DMAP)B(pz)3] (9b) (120 mg, 0.36 mmol) was then added in small 
portions and a colour change from orange to yellow was observed. The reaction was stirred for a further 24 h 
at room temperature. NH4PF6 (60 mg, 0.37 mmol) was added to the solution and a yellow precipitate was 
formed. The precipitate was isolated by cannula filtration, dried and washed with ether to afford 120 mg of a 
yellow solid (37%). The product was crystallized by slow diffusion of diethyl ether into an acetonitrile 
solution to obtain crystals suitable for X- ray crystallography. 
1
H nmr (360.1 MHz, DMSO): δH 8.18 (3H, d, J 
= 2.2 Hz), 7.46 (3H, J = 2.6 Hz), 7.03 (2H, d, J = 7.8 Hz), 6.90 (2H, d, J = 7.4 Hz), 6.68 (3H, t, J = 2.2 Hz), 
5.77 (2H, d, J = 6.1 Hz), 4.92 (2H d, J = 6.1 Hz), 3.22 (6H, s), 2.66 (1H, sept, J = 6.5 Hz), 1.56 (3H, s), 1.76 
(6H, d, J = 6.5 Hz); 
13
C nmr (90.5 MHz, DMSO): δC 156.7 (Cq DMAP), 148.5 (Cq p-cym), 142.2 (CH pz), 138.2 
(CH pz), 128.7 (CH q p-cym), 108.3 (CH DMAP), 107.8 (CH p-cym), 102.6 (CH pz), 101.9 (CH p- cym), 107.2 (C DMAP), 
80.3 (CH3 pz), 29.9 (CH3 DMAP), 22.1 (CH3 P-cym), 17.4 (CH3 p-cym); MS (FAB
+
) m/z = 605.2 (M
+
); Anal. Calcd. 
for C26H33BClF6N8PRu: C, 41.64; H, 4.44; N, 14.94; found: C, 41.53; H, 4.35; N, 14.56 %. 
[{(N-methylimidazole)B(methimazolyl)3}Mn(CO)3][PF6] (12): Ligand 9a (0.100 g, 0.23 mmol) was added in 
small portions to a solution of [Mn(CO)3(MeCN)3]PF6 (0.094 g, 0.23 mmol) dissolved in MeCN (10 mL) and 
the mixture was then heated to reflux for 2 hours providing a yellow precipitate. After cooling the solid was 
filtered via cannula, washed with hexane (10 mL) and dried under vacuum to yield 12 as a yellow solid.(0.095 
g, 0.17 mmol, 70%). 
1
H-NMR (250.1 MHz, CDCl3), 8.83 (s, 1H), 7.70 (s, 1H), 7.67 (s, 1H), 7,38 (d, 3H, J 
=2.34Hz), 6.82 (d, 3H, J = 2.34Hz), 3.83 (s, 3H), 3.55 (s, 9H); 
13
C-NMR (62.9 MHz, CDCl3), 209.45 
(C=O), 162.7 (C=S), 141.4 (CHimi); 125.6 (CHimi), 124.3 (CHmet), 122.6 (CHimi), 121.5 (CHmet), 40.4 
(CH3imi), 35.1 (CH3met); 
11
B-NMR (80.3 MHz, DMSO-d6), 4.07; MS (EI +25eV): M
+
= 571.9; IR (MeCN 
solution): 2007, 1914 cm
-1 
(CO); Anal. Calcd for C19H21BN8S3O3MnPF6; C, 31.86; H, 2.95; N, 15.64. Found: 
C, 31.72; H, 2.89; N, 15.70. 
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[{(N-methylimidazole)B(pyrazolyl)3}Mn(CO)3][PF6] (13): To a solution of [Mn(CO)3(MeCN)3]PF6 (0.141 g, 
0.34 mmol) in acetonitrile (10 mL), ligand 9b (0.100 g, 0.34 mmol) was added in small portions. The mixture 
was heated to reflux and the reaction was monitored by ES mass spectrometry. After 5h starting materials 
were no longer detected and the mixture was cooled to room temperature. Half of the solvent was removed 
under vacuum and the remaining solution was layered with dry Et2O (15 mL) and stored at 5ºC overnight. A 
pale yellow solid precipitated, which was filtered off, washed with Et2O (10 mL) and dried under vacuum to 
yield (13) as a pale yellow solid. (0.110 g, 0.25 mmol, 75%). Crystals suitable for X-ray were obtained by 
slow diffusion of Et2O into a solution of 13 in acetone. 
1
H-NMR (250.1 MHz, DMSO-d6),  9.69 (s, 1H), 
8.36 (s, 1H), 8.23 (s, 1H), 8.17 (s, 3H), 8.09 (s, 3H), 6.55 (s, 3H), 3.86 (s, 3H); 
13
C-NMR (62.9 MHz, CDCl3), 
206.9 (CO), 147.2 (CHimi); 141.5 (CHimi), 136.2 (CHimi), 125.4 (CHpy), 125.1 (CHpy), 108.0 (CHpy), 
36.4 (CH3imi); 
11
B-NMR (80.3 MHz, DMSO-d6),  1.90.; MS (EI +25eV): M
+
= 433 (M+1); IR(MeCN): 
2041, 1941 cm
-1
 (CO); Anal. Calcd for C16H15N8BO3MnPF6: C, 33.24; H, 2.62; N, 19.38. Found: C, 33.06; H, 
2.50; N, 19.45. 
X-ray crystallography: Crystal data for 8, 11, 12 and 13 are presented in Table 4. All data sets were collected 
with Mo-K radiation (= 0.71073 Å) on a Bruker SMART APEX CCD diffractometer equipped with an 
Oxford Cryosystems low-temperature device operating at 150 K. Absorption corrections were carried out 
using the multi-scan procedure SADABS.
[29]
 The structures were solved by Patterson methods for 8 and 11, 
DIRDIF
[30]
 and by direct methods for 12 and SIR-92
[31]
 for 13. All structures were refined by full-matrix least-
squares against F
2
 using SHELXL-97
[32] 
for 8 and 11 and CRYSTALS
[33]
 for 12 and 13. All non-hydrogen 
atoms were refined anisotropically, while hydrogen atoms were placed in calculated positions, constrained to 
ride on their carbon atoms with group Uiso values assigned [Uiso(H)= 1.2Uiso for aromatic carbons and 1.5Uiso 
for methyl atoms]. In 8 the PF6
-
 anion based on P2 is disordered about one F-P-F axis. The occupancies of 
each component were fixed at 0.5 after competitive refinement. The geometries of the components were 
restrained to be similar. C34 is disordered over two positions, also in the ratio 0.5:0.5. The C24-C34-C44 and 
C23- C34'-C44 fragments were restrained to be geometrically similar. The structures of 8 and 12 contained 
disordered solvent regions which were were treated using the Squeeze procedure.
[34]
 In 8 the number of 
electrons treated equates to 1 MeCN per formula unit; in 12 the number equates to 1 MeCN and 1 CH2Cl2 per 
formula unit. The values of F(000), D, M and mu are all calculated on this assumption. The imidazole ring in 
13 is disordered over two orientations in the ratio 0.68:0.32. One carbon atom in the ring is common to both 
sites, as is the methyl carbon. The PF6
-
 counterion is also disordered. The 4 equatorial F atoms have been 
modelled as a torus of electron density as described by Schroder et al.
[35]
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 8 11 12 13 
Crystal 
Description 
Red block Orange block Yellow needle Yellow block 
Empirical 
Formula 
C31H44BF12N9
P2RuS3 
[RuL(cymene)
][PF6]2.MeCN 
C26 H33 B Cl F6 
N8 P Ru             
[Ru(C16H19BN8)(
C10H14)Cl]
+
 PF6
-
 
C22 H26 B Cl2 F6 
Mn N9 O3 P S3                     
[MnL(CO)3][PF
6].MeCN.CH2Cl
2  
C16 H15 B F6 Mn 
N8 O3 P                  
[Mn (CO)3 (C13 
H15 B N8)] [PF6]  
Mw 1040.75 749.9 842.31 578.05 
T(K) 150(2) 150(2) 150(2) 150(2) 
Crystal system Monoclinic monoclinic triclinic monoclinic 
space group P21/c P21/c P-1 P21/c 
a (Å) 16.7640(5) 15.3059(5) 10.1485(4) 22.6630(9)  
b (Å) 13.0602(4) 10.1443(3) 10.5216(4) 7.7096(3) 
c (Å) 20.5423(6) 20.8293(7) 17.4682(7) 13.3115(6) 
() 90 90 103.199(2) 90 
() 94.485(2) 106.854(2) 94.290(2) 101.201(2) 
() 90 90 106.470(2) 90 
V(Å
3
) 4483.8(2) 3095.20(17) 1721.88(12) 2281.52(16) 
Z 4 4 2 4 
(Cu-K) (mm-
1
) 
0.646 0.713 0.841 0.735 
Independent 
reflections 
8811 [R(int) = 
0.0674] 
6359 [R(int) = 
0.0578] 
9595 [R(int) = 
0.041] 
6286 [R(int) = 
0.040] 
Data with |F|  
4 (|F|)] 
7122 5123 4373 4627 
Absorption 
correction 
Multiscan 
(Tmin = 0.334, 
Tmax = 0.827) 
Semi-empirical 
from equivalents 
(Tmin = 0.7707, 
Tmax = 0.9168) 
Semi-empirical 
from equivalents 
(Tmin = 0.74, 
Tmax = 0.93) 
Semi-empirical 
from equivalents 
(Tmin = 0.61, 
Tmax = 0.90) 
R 0.0452 0.0347 0.0664 0.0915 
 
Table 4. Crystallographic data for [(DBN)B(methimazolyl)3}Ru(p-cymene)][PF6]2 (8), 
[{(DMAP)B(pz)3}Ru(p-cymene)Cl]PF6 (11), [{(1-methylimidazole)-B(methimazolyl)3}Mn(CO)3][PF6] (12) 
and [{(1-methylimidazole)B(pyrazolyl)3}Mn(CO)3][PF6] (13). 
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